×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Endoscopic Ultrasound Needles Market

ID: MRFR/MED/51765-HCR
200 Pages
Rahul Gotadki
February 2026

China Endoscopic Ultrasound Needles Market Research Report By Type (Fine Needle Aspiration Needles, Core Biopsy Needles, Aspiration Needles), By Application (Pancreatic Diseases, Liver Diseases, Lung Diseases, Gastrointestinal Disorders), By End Use (Hospitals, Diagnostic Laboratories, Specialty Clinics) and By Material (Stainless Steel, Plastic, Composite Materials) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Endoscopic Ultrasound Needles Market Infographic
Purchase Options

China Endoscopic Ultrasound Needles Market Summary

As per Market Research Future analysis, the China endoscopic ultrasound-needles market size was estimated at 12.75 USD Million in 2024. The China endoscopic ultrasound-needles market is projected to grow from 13.62 USD Million in 2025 to 26.4 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6.8% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The China The endoscopic ultrasound-needles market is poised for growth. This growth is driven by technological advancements and an increasing demand for minimally invasive procedures.

  • Technological advancements are enhancing the efficacy and precision of endoscopic ultrasound-needles.
  • The largest segment in the market is the gastrointestinal segment, reflecting the high prevalence of related disorders.
  • The fastest-growing segment is the oncology segment, driven by rising awareness of early diagnosis.
  • Key market drivers include the increasing prevalence of gastrointestinal disorders and investment in healthcare infrastructure.

Market Size & Forecast

2024 Market Size 12.75 (USD Million)
2035 Market Size 26.4 (USD Million)
CAGR (2025 - 2035) 6.84%

Major Players

Boston Scientific (US), Medtronic (US), Cook Medical (US), Olympus Corporation (JP), ConMed Corporation (US), Fujifilm Holdings Corporation (JP), Hologic, Inc. (US), B. Braun Melsungen AG (DE)

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

China Endoscopic Ultrasound Needles Market Trends

The endoscopic ultrasound-needles market is currently experiencing notable growth. This growth is driven by advancements in medical technology and an increasing prevalence of gastrointestinal disorders. The demand for minimally invasive procedures is rising, as healthcare providers seek to enhance patient outcomes while reducing recovery times. In China, the healthcare sector is undergoing significant transformation, with a focus on improving diagnostic capabilities and treatment options. This shift is likely to bolster the adoption of endoscopic ultrasound-needles, as they offer precision and efficiency in various medical applications. Moreover, the regulatory environment in China appears to be evolving, with authorities emphasizing the importance of quality and safety in medical devices. This trend may lead to increased investments in research and development, fostering innovation within the endoscopic ultrasound-needles market. As healthcare professionals become more familiar with these tools, their integration into clinical practice is expected to expand. Overall, the endoscopic ultrasound-needles market is poised for continued growth, reflecting broader trends in healthcare that prioritize patient-centered approaches and technological advancements.

Technological Advancements

The endoscopic ultrasound-needles market is witnessing rapid technological innovations, enhancing the precision and effectiveness of procedures. New designs and materials are being developed to improve the performance of these needles, which may lead to better patient outcomes and increased adoption in clinical settings.

Rising Demand for Minimally Invasive Procedures

There is a growing preference for minimally invasive techniques among healthcare providers and patients alike. This trend is likely to drive the endoscopic ultrasound-needles market, as these tools facilitate less traumatic interventions, resulting in shorter recovery times and reduced hospital stays.

Regulatory Changes and Quality Standards

The regulatory landscape in China is evolving, with a stronger emphasis on quality and safety standards for medical devices. This shift may encourage manufacturers to invest in higher-quality products, potentially enhancing the overall reliability and effectiveness of the endoscopic ultrasound-needles market.

China Endoscopic Ultrasound Needles Market Drivers

Rising Geriatric Population

The increasing geriatric population in China is a significant driver for the endoscopic ultrasound-needles market. As the population ages, the prevalence of age-related health issues, including gastrointestinal disorders, is likely to rise. Reports indicate that by 2030, approximately 25% of China's population will be over 60 years old, creating a substantial demand for effective diagnostic tools. Endoscopic ultrasound-needles are particularly valuable in this demographic, as they facilitate minimally invasive procedures that are safer for older patients. The endoscopic ultrasound-needles market is expected to benefit from this demographic shift. Healthcare providers are seeking to address the unique needs of the aging population, thereby enhancing the overall demand for these specialized medical instruments.

Growing Awareness of Early Diagnosis

There is a notable increase in awareness regarding the importance of early diagnosis of diseases in China, which serves as a key driver for the endoscopic ultrasound-needles market. Public health campaigns and educational initiatives have emphasized the benefits of early detection, particularly for cancers and other serious conditions. This heightened awareness is likely to lead to an increase in diagnostic procedures, where endoscopic ultrasound-needles are essential for accurate assessments. As patients become more proactive about their health, the demand for effective diagnostic tools is expected to rise. Consequently, the endoscopic ultrasound-needles market may witness a surge in usage as healthcare providers respond to this growing demand for early diagnostic capabilities.

Investment in Healthcare Infrastructure

China's ongoing investment in healthcare infrastructure is a significant driver for the endoscopic ultrasound-needles market. The government has been actively enhancing healthcare facilities, particularly in urban areas, to improve access to advanced medical technologies. Recent reports indicate that healthcare expenditure in China is projected to reach approximately $1 trillion by 2025, reflecting a commitment to modernizing healthcare services. This investment is likely to facilitate the acquisition of advanced diagnostic tools, including endoscopic ultrasound-needles, thereby expanding their availability in hospitals and clinics. As healthcare providers upgrade their facilities and technologies, the endoscopic ultrasound-needles market is expected to experience substantial growth, driven by increased adoption rates and improved patient care.

Technological Integration in Medical Practices

The integration of advanced technologies in medical practices is transforming the landscape of the endoscopic ultrasound-needles market. Innovations such as artificial intelligence and machine learning are being incorporated into diagnostic procedures, enhancing the precision and efficiency of endoscopic ultrasound techniques. This technological evolution is likely to improve the overall effectiveness of endoscopic ultrasound-needles, making them more appealing to healthcare providers. As hospitals and clinics in China adopt these cutting-edge technologies, the endoscopic ultrasound-needles market is expected to expand, driven by the demand for enhanced diagnostic capabilities and improved patient outcomes. The potential for technological advancements to streamline procedures and reduce complications further supports the growth of this market.

Increasing Prevalence of Gastrointestinal Disorders

The rising incidence of gastrointestinal disorders in China is a crucial driver for the endoscopic ultrasound-needles market. Conditions such as pancreatitis, gastrointestinal cancers, and inflammatory bowel diseases are becoming more prevalent, necessitating advanced diagnostic tools. According to health statistics, the prevalence of gastrointestinal cancers has increased by approximately 20% over the past decade. This trend underscores the need for effective diagnostic procedures, where endoscopic ultrasound-needles play a vital role. As healthcare providers seek to enhance diagnostic accuracy and patient outcomes, the demand for these specialized needles is expected to grow significantly. The endoscopic ultrasound-needles market is likely to benefit from this increasing patient population. More healthcare facilities are adopting these technologies to meet the rising demand for precise and minimally invasive diagnostic solutions.

Market Segment Insights

By Type: Fine Needle Aspiration Needles (Largest) vs. Core Biopsy Needles (Fastest-Growing)

In the China endoscopic ultrasound-needles market, Fine Needle Aspiration Needles hold the largest market share, largely due to their widespread application in various diagnostic procedures. This segment's popularity stems from its ability to provide accurate cytological specimens with minimal discomfort to patients. Core Biopsy Needles, while currently holding a smaller share, are witnessing rapid adoption owing to advancements in needle design and technique, enabling better sample retrieval for histopathological analysis. Growth trends in the segment highlight an increasing preference for minimally invasive procedures, which has accelerated the utilization of both Fine Needle Aspiration and Core Biopsy Needles. The rise of healthcare facilities focusing on enhanced patient outcomes drives demand, alongside technological innovations in needle manufacturing and designs. Additionally, the growing prevalence of chronic diseases necessitates regular diagnostic procedures, further boosting the market for these needles.

Aspiration Needles: Dominant vs. Core Biopsy Needles: Emerging

Aspiration Needles currently dominate the China endoscopic ultrasound-needles market due to their established role in fluid aspiration for diagnostic analysis, showcasing their reliability and efficiency during procedures. This segment benefits from a broad range of applications in oncology and gastroenterology, where rapid results are often crucial. Conversely, Core Biopsy Needles are an emerging segment, increasingly gaining traction thanks to improved accuracy in tissue sampling. Their design, aimed at minimizing trauma while maximizing yield, is appealing to both healthcare providers and patients. As healthcare professionals continue to favor precision-driven tools, the Core Biopsy Needle segment is poised for remarkable growth, driven by innovations and a shift towards comprehensive diagnostic strategies.

By Application: Pancreatic Diseases (Largest) vs. Liver Diseases (Fastest-Growing)

In the market, pancreatic diseases constitute the largest segment, demonstrating a significant share due to the rising prevalence of pancreatic disorders in the population. Following closely is liver diseases, which has been gaining traction as a noteworthy segment, highlighting the growing emphasis on liver health and the advancements in diagnostic techniques. The distribution is indicative of a paradigm shift towards more organ-specific diagnostics in the market. Growth trends indicate that liver diseases are emerging as the fastest-growing segment, spurred by increasing awareness and earlier diagnoses. Meanwhile, pancreatic diseases continue to dominate, supported by a robust pipeline of innovative treatment options. With advancements in technology, there is also an appreciation for less invasive procedures, creating a compelling case for both segments in the evolving landscape of healthcare.

Gastrointestinal Disorders (Dominant) vs. Lung Diseases (Emerging)

Gastrointestinal disorders remain a dominant force in the market, reflecting the high incidence of digestive issues and the consequent demand for effective diagnostic tools. This segment benefits from established treatments and a broad range of endoscopic ultrasound applications. In contrast, lung diseases are emerging as a significant area of interest, driven by rising respiratory health concerns and innovations in diagnostic methodologies. Lung diseases are increasingly recognized for their complex nature, requiring sophisticated endoscopic interventions, which is promoting research and development in this segment. As a result, the market for lung disease endoscopic ultrasound-needles is set to expand with the introduction of more advanced solutions.

By End Use: Hospitals (Largest) vs. Specialty Clinics (Fastest-Growing)

In the China endoscopic ultrasound-needles market, hospitals hold the largest market share, serving as the primary users due to their extensive resources and capabilities for advanced medical procedures. Diagnostic laboratories also contribute significantly, catering to various testing and diagnostic needs. Specialty clinics, while smaller in share, are emerging rapidly, driven by a growing trend towards less invasive procedures and specialized care. The growth trends in this segment are propelled by increasing healthcare investments and advancements in endoscopic technologies. Hospitals are expanding their capabilities to perform a wider range of procedures, while specialty clinics are capitalizing on the demand for rapid and effective diagnostic solutions. The rise in chronic diseases and the need for early diagnosis further boost the adoption of endoscopic ultrasound needles across these settings.

Hospitals (Dominant) vs. Specialty Clinics (Emerging)

Hospitals play a dominant role in the China endoscopic ultrasound-needles market due to their extensive infrastructure and trained medical personnel, allowing them to perform a vast array of diagnostic and therapeutic procedures. The integration of advanced technologies in hospitals enhances their operational effectiveness and patient outcomes. On the other hand, specialty clinics are emerging as key players by focusing on niche markets and personalized care. They benefit from flexible operational models and lower overhead costs, enabling them to adopt new technologies swiftly. The combination of specialized expertise and targeted treatments positions specialty clinics as a significant growth area in the market, appealing to patients seeking quicker and more efficient healthcare solutions.

By Material: Stainless Steel (Largest) vs. Plastic (Fastest-Growing)

In the China endoscopic ultrasound-needles market, Stainless Steel is recognized as the largest segment, accounting for a significant share due to its durability, strength, and superior performance in clinical settings. The Plastic segment, while smaller, is rapidly gaining traction, driven by innovations in material science and the demand for lightweight, cost-effective solutions. Composite Materials also play a role but are currently limited in market share compared to their counterparts. Growth trends in this market are largely influenced by the increasing demand for minimally invasive procedures and advancements in technology. Stainless Steel continues to dominate because of its reliability, while the rise in outpatient surgeries enhances the appeal of Plastic needles. As healthcare practices evolve, the development of Composite Materials is expected to present additional opportunities for growth in the upcoming years.

Stainless Steel (Dominant) vs. Plastic (Emerging)

The Stainless Steel segment is characterized by its established market position and is favored for its high strength-to-weight ratio, resistance to corrosion, and ability to maintain sharpness during procedures. Its market dominance stems from widespread acceptance among healthcare professionals. Conversely, the Plastic segment is emerging, capturing interest due to its potential for reducing costs and improving patient comfort. The lightweight nature of Plastic needles facilitates ease of use during procedures, making them appealing for various applications. While Stainless Steel remains the preferred choice in critical situations, the growing acceptance of Plastic needles in certain medical settings indicates a shift towards more versatile options in the sector.

Get more detailed insights about China Endoscopic Ultrasound Needles Market

Key Players and Competitive Insights

The endoscopic ultrasound-needles market in China is characterized by a competitive landscape that is both dynamic and multifaceted. Key growth drivers include the increasing prevalence of gastrointestinal disorders, advancements in minimally invasive surgical techniques, and a growing emphasis on early diagnosis. Major players such as Boston Scientific (US), Medtronic (US), and Olympus Corporation (JP) are strategically positioned to leverage these trends. Boston Scientific (US) focuses on innovation and product development, particularly in enhancing the efficacy of their ultrasound-needle systems. Medtronic (US) emphasizes regional expansion and partnerships to strengthen its market presence, while Olympus Corporation (JP) is committed to digital transformation and integrating advanced imaging technologies into its offerings. Collectively, these strategies contribute to a competitive environment that is increasingly centered around technological advancement and patient-centric solutions.
In terms of business tactics, companies are localizing manufacturing to reduce costs and improve supply chain efficiency. The market structure appears moderately fragmented, with several key players holding substantial market shares. This fragmentation allows for a diverse range of products and innovations, although it also intensifies competition among established and emerging firms. The collective influence of these key players shapes market dynamics, as they vie for leadership through strategic initiatives and operational excellence.
In October 2025, Boston Scientific (US) announced the launch of a new line of endoscopic ultrasound-needles designed to enhance precision in tissue sampling. This strategic move is significant as it not only reinforces the company's commitment to innovation but also addresses the growing demand for more accurate diagnostic tools in the Chinese healthcare market. By introducing advanced technology, Boston Scientific (US) aims to capture a larger share of the market and improve patient outcomes.
In September 2025, Medtronic (US) entered into a partnership with a leading Chinese healthcare provider to expand its distribution network for endoscopic ultrasound-needles. This collaboration is crucial as it allows Medtronic (US) to enhance its market reach and adapt its products to local needs, thereby positioning itself more favorably against competitors. Such strategic alliances are likely to bolster Medtronic's (US) presence in a rapidly evolving market.
In August 2025, Olympus Corporation (JP) unveiled a new digital platform that integrates AI technology into its endoscopic ultrasound systems. This initiative is indicative of the company's focus on digital transformation and reflects a broader trend within the industry towards the incorporation of advanced technologies. By leveraging AI, Olympus Corporation (JP) aims to improve diagnostic accuracy and streamline workflows, which could provide a competitive edge in the market.
As of November 2025, current competitive trends in the endoscopic ultrasound-needles market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological innovation, enhanced patient care, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive advantage.

Key Companies in the China Endoscopic Ultrasound Needles Market include

Industry Developments

In recent months, the China Endoscopic Ultrasound Needles Market has experienced significant advancements and developments. Companies such as TaeWoong Medical, Cook Medical, and Boston Scientific are collaborating to enhance product offerings and expand their market presence. The rapid growth of minimally invasive procedures and an increasing geriatric population are driving demand for endoscopic ultrasound needles. 

Furthermore, the market valuation of key players, including Abbott and Medtronic, has been positively impacted by increased healthcare expenditure in China, focusing on advanced surgical technologies. In terms of mergers and acquisitions, in September 2022, Stryker announced its acquisition of a specialized endoscopic needle manufacturer, solidifying its foothold in the Chinese market. 

Additionally, EUS Medical received regulatory approvals for its innovative products aimed at improving patient outcomes in March 2023. Major happenings in the market include Fujifilm's launch of new endoscopic ultrasound technologies in November 2021, which are designed to meet the growing demand for precision healthcare. The current focus remains on product innovation and strategic partnerships to cater to the evolving needs of the healthcare landscape in China.

 

Future Outlook

China Endoscopic Ultrasound Needles Market Future Outlook

The Endoscopic Ultrasound Needles Market in China is projected to grow at a 6.84% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare investments.

New opportunities lie in:

  • Development of advanced needle designs for improved precision
  • Expansion of telemedicine platforms integrating ultrasound technology
  • Partnerships with hospitals for exclusive supply agreements

By 2035, the market is expected to achieve substantial growth and innovation.

Market Segmentation

China Endoscopic Ultrasound Needles Market Type Outlook

  • Fine Needle Aspiration Needles
  • Core Biopsy Needles
  • Aspiration Needles

China Endoscopic Ultrasound Needles Market End Use Outlook

  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics

China Endoscopic Ultrasound Needles Market Material Outlook

  • Stainless Steel
  • Plastic
  • Composite Materials

China Endoscopic Ultrasound Needles Market Application Outlook

  • Pancreatic Diseases
  • Liver Diseases
  • Lung Diseases
  • Gastrointestinal Disorders

Report Scope

MARKET SIZE 2024 12.75(USD Million)
MARKET SIZE 2025 13.62(USD Million)
MARKET SIZE 2035 26.4(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.84% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Boston Scientific (US), Medtronic (US), Cook Medical (US), Olympus Corporation (JP), ConMed Corporation (US), Fujifilm Holdings Corporation (JP), Hologic, Inc. (US), B. Braun Melsungen AG (DE)
Segments Covered Type, Application, End Use, Material
Key Market Opportunities Advancements in minimally invasive techniques drive growth in the endoscopic ultrasound-needles market.
Key Market Dynamics Rising demand for minimally invasive procedures drives innovation in endoscopic ultrasound-needles technology and market competition.
Countries Covered China
Leave a Comment

FAQs

What is the expected market size of the China Endoscopic Ultrasound Needles Market in 2024?

The market is expected to be valued at 72.75 USD million in 2024.

How much is the market projected to be worth by 2035?

The market is projected to be valued at 120.0 USD million by 2035.

What is the expected CAGR for the China Endoscopic Ultrasound Needles Market from 2025 to 2035?

The expected CAGR for the market is 4.655% from 2025 to 2035.

Which type of endoscopic ultrasound needle is valued the highest in 2024?

The Fine Needle Aspiration Needles are valued the highest at 28.0 USD million in 2024.

What is the market size for Core Biopsy Needles in 2035?

The market size for Core Biopsy Needles is expected to be 40.0 USD million in 2035.

Who are the major players in the China Endoscopic Ultrasound Needles Market?

Major players include TaeWoong Medical, Cook Medical, Boston Scientific, and Abbott among others.

What is the market size of Aspiration Needles in 2024?

Aspiration Needles are valued at 20.0 USD million in 2024.

What growth is expected for the Fine Needle Aspiration Needles by 2035?

The Fine Needle Aspiration Needles market is expected to grow to 45.02 USD million by 2035.

What are the anticipated trends in the China Endoscopic Ultrasound Needles Market?

The market is expected to see growth driven by advancements in technology and increasing demand for minimally invasive procedures.

What is the significance of regional dynamics in the China Endoscopic Ultrasound Needles Market?

Regional dynamics play a crucial role in market growth, as healthcare advancements vary across different regions in China.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions